Outlook Therapeutics (OTLK) announced Faisal Sukhtian has been appointed as Chairman of the Board of Directors, effective immediately. Sukhtian will assume the role from Randy Thurman, who will remain on the Board as Lead Independent Director.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics announces presentation of data from NORSE EIGHT
- Outlook Therapeutics enters into agreement for warrant inducement transaction
- Outlook Therapeutics’ ONS-5010 shown to be non-inferior to Lucentis in wet AMD
- Biotech Alert: Searches spiking for these stocks today
- Outlook Therapeutics Faces Business Risks from Third-Party Manufacturing Dependencies